TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Reviva Bio AB
Closing information (x1000 EUR)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
1,566
|
1,040
|
1,010 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
123
|
105
|
174 |
EBITDA |
132
|
112
|
181 |
Total assets |
1,109
|
603
|
524 |
Current assets |
1,081
|
578
|
499 |
Current liabilities |
552
|
128
|
97 |
Equity capital |
495
|
413
|
363 |
- share capital |
4
![]() |
4
|
5 |
Employees (average) |
11
|
8
![]() |
8 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
44.6%
|
68.5%
|
69.3% |
Turnover per employee |
142
|
130
|
126 |
Profit as a percentage of turnover |
7.9%
|
10.1%
|
17.2% |
Return on assets (ROA) |
11.2%
|
17.4%
|
33.2% |
Current ratio |
195.8%
|
451.6%
|
514.4% |
Return on equity (ROE) |
24.8%
|
25.4%
|
47.9% |
Change turnover |
564
|
120
|
270 |
Change turnover % |
56%
|
13%
|
37% |
Chg. No. of employees |
3
|
0
|
1 |
Chg. No. of employees % |
38%
|
0%
|
14% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.